NCT04371510View on ClinicalTrials.gov

Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 20, 2020

Primary Completion Date

August 27, 2021

Study Completion Date

August 27, 2021

Conditions
COVID-19 by SARS-CoV-2 Infection
Interventions
OTHER

blood sample

a blood sample is taken on Covid-19 chronic haemodialysis patients with moderate symptoms

Trial Locations (1)

06001

CHU de nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04371510 - Blood Biomarkers as Predictors of COVID-19 Disease Progression in Recently Infected Chronic Haemodialysis Patients | Biotech Hunter | Biotech Hunter